New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation
Abstract C407 is a compound that corrects the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein carrying the p.Phe508del (F508del) mutation. We investigated the corrector effect of c407 and its derivatives on F508del-CFTR protein. Molecular docking and dynamics simulations combined...
Main Authors: | Sara Bitam, Ahmad Elbahnsi, Geordie Creste, Iwona Pranke, Benoit Chevalier, Farouk Berhal, Brice Hoffmann, Nathalie Servel, Danielle Tondelier, Aurelie Hatton, Christelle Moquereau, Mélanie Faria Da Cunha, Alexandra Pastor, Agathe Lepissier, Alexandre Hinzpeter, Jean-Paul Mornon, Guillaume Prestat, Aleksander Edelman, Isabelle Callebaut, Christine Gravier-Pelletier, Isabelle Sermet-Gaudelus |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-83240-x |
Similar Items
-
Author Correction: New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation
by: Sara Bitam, et al.
Published: (2021-09-01) -
An unexpected effect of TNF-α on F508del-CFTR maturation and function [v2; ref status: indexed, http://f1000r.es/5tv]
by: Sara Bitam, et al.
Published: (2015-09-01) -
An unexpected effect of TNF-α on F508del-CFTR maturation and function [v1; ref status: indexed, http://f1000r.es/5jf]
by: Sara Bitam, et al.
Published: (2015-07-01) -
Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
by: Iwona Pranke, et al.
Published: (2019-02-01) -
Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation
by: Isabelle Sermet-Gaudelus
Published: (2013-03-01)